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Persistent infection with Japanese encephalitis virus (JEV) was established in murine neuroblastoma N18 cells, and the
persistency has been maintained in cell culture for over 6 months. From the persistently infected cells, a clone named C2-
2 was selected and expanded to form a stable cell line. The vast majority of C2-2 cells showed viral protein staining by
immunofluorescence and continuously produced low levels of virus (103 to 104 PFU/ml) without marked cytopathic effects
or cyclic variations. In addition to the wild-type viral proteins, truncated forms of the viral nonstructural protein 1 (NS1) as
well as its derivative NS1* were produced in C2-2 cells. Both truncated NS1 and NS1* contain deletions at their N-termini;
however, the analyses by RT–PCR and direct sequencing of the viral RNA failed to detect any truncations or mutations
within the NS1 region, suggesting that NS1 truncation was a result of a unique posttranslational proteolytic cleavage of
NS1 in the persistently infected cells. Similar but not identical truncation of NS1 was also observed in two other persistently
infected cell lines established in Vero and DBT (murine astrocytoma) cells. However, viruses released from C2-2 cells did
not produce truncated NS1 upon infection of N18 cells, suggesting that NS1 truncations were the result of virus–cell
interaction in persistently infected cells. These data indicate a strong association between abnormal NS1 expression and
JEV persistency. A probable involvement of dysfunctional NS1 in the establishment and/or maintenance of JEV persistency
in tissue culture is discussed. q 1996 Academic Press, Inc.
der. Characteristically, the order of flaviviral proteins isINTRODUCTION
5*-C-prM(M)-E-NS1-NS2A2B-NS3-NS4A4B-NS5-3 *.
The nonstructural proteins in JEV-infected cells com-Japanese encephalitis virus (JEV) is a member of the
prise a glycosylated NS1; two hydrophilic proteins, NS3Flaviviridae and causes acute encephalitis in humans
and NS5; and four small hydrophobic proteins, NS2A,with a high mortality rate (Burke and Leake, 1988; Vaughn
NS2B, NS4A, and NS4B, associated with the cellularand Hoke, 1992). Similar to the majority of viruses in this
membrane (Hashimoto et al., 1990; Nitayaphan et al.,family, JEV is arthropod-borne and transmitted to human
1990; Sumiyoshi et al., 1987). NS1 has a predicted molec-through persistently infected mosquito vectors. In the
ular weight of 42 kDa, with two N-linked carbohydratenatural life cycle of JEV, human is the dead-end host,
chains at positions 105 and 182; however, the actual sizewhile other vertebrates, such as swine, serve as an am-
of NS1 in JEV-infected cells is approximately 48 kDa.plifying reservoir for the maintenance of JEV (Chambers
The proteolytic cleavage of E–NS1 is followed by theet al., 1990).
translocation of NS1 into the lumen of the endoplasmicThe JEV genome is a single-stranded, positive-sense
reticulum (ER), and the cleavage of NS1–2A is thoughtRNA of approximately 11 kb and contains an open read-
to take place in the lumen of vesicular compartmentsing frame of more than 10 kb encoding a polyprotein
(Chambers et al., 1990). An additional NS1–2A-related(reviewed in Chambers et al., 1990). In the infected cells,
protein (named as NS1*) of 56 kDa is often observedthe polyprotein is proteolytically cleaved by cellular and
in JEV-infected cells (Mason, 1989) and is presumablyviral proteases into more than 10 viral proteins. The struc-
generated by a protease which recognizes an alternativetural proteins, including capsid (C), precursor of mem-
cleavage site within NS2A (Jan et al., 1995). It has beenbrane (prM), and envelope (E), are encoded in the 5*
suggested that NS1 may play a role in virion maturation,quarter of the genome, and the nonstructural proteins,
since NS1 is coretained with the immature forms of thedesignated NS1 through NS5, are encoded in the remain-
structural glycoprotein E in the ER of JEV-infected cells
(Fan and Mason, 1990). Nonetheless, the exact biological
functions of NS1 and NS1* in JEV replication remain un-1 To whom correspondence and reprint requests should be ad-
clear.dressed. Fax: (886)-2-672-9820; E-mail: lkchen@ndmc1.ndmctsgh.
edu.tw. JEV is usually cytolytic for susceptible cells; yet, persis-
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tent infection has been demonstrated in cell cultures counted, diluted with medium, and distributed into a 96-
well microtiter plate. Each well, which contained an aver-(Schmaljohn and Blair, 1977, 1979; Shah and Gadkari,
1987) as well as in a mouse model (Mathur et al., 1986). age of one cell, was microscopically observed daily for
the presence of cell colonies. Once they became conflu-Moreover, in the human, latent infection of mononuclear
cells in the peripheral blood from JEV-infected patients ent in wells, cells were trypsinized and transferred to
new 25-cm tissue culture flasks for further growth.has been documented (Sharma et al., 1991); viral persis-
tency in the human nervous system has been shown in
Generation and characterization of monoclonalapproximately 5% of JEV-associated encephalitis (Ravi et
antibodiesal., 1993), suggesting that it might be responsible for the
neural sequelae after acute infection phase. The precise
Six- to eight-week-old BALB/c mice were immunized
mechanism for JEV persistency in vitro and in vivo has
intraperitoneally with JEV-infected suckling mouse brain
not been fully understood. One of the possible mecha-
suspensions mixed with an equal volume of Freund’s
nisms that have been suggested for other flaviviruses
complete adjuvant for first inoculation, and incomplete
to persist in cell cultures is the production of defective
Freund’s adjuvant was used for subsequent boosting.
interfering (DI) particles (Brinton, 1986; Poidinger et al.,
JEV-specific antisera were obtained from the mice after
1991; Schmaljohn and Blair, 1977). However, the produc-
three consecutive challenges. For generation of mono-
tion of DI virus has not been universally observed. The
clonal antibodies, splenocytes were fused with NS-1 my-
present study describes the establishment of persistent
eloma cells and selected as described by Kohler and
JEV infection in murine neuroblastoma N18 cells and
Milstein (1976). The hybridoma secreting specific anti-
demonstrates a novel mechanism of persistent infection
bodies were identified by ELISA as described by Heinz
involving the synthesis of an abnormal NS1 protein. To
et al. (1983) and by immunoprecipitation assays using
the best of our knowledge, this is the first report of persis-
JEV-infected BHK-21 cell lysates as antigen source. Sin-
tent JEV infection in immortalized neuronal cells. This
gle-cell clones were generated by limiting dilution and
system provides an in vitro model for studying the molec-
the cells were injected into incomplete Freund’s adju-
ular process of persistent JEV infection in neurons. Deter-
vant-primed BALB/c mice for ascitic fluid production.
mination of viral and cellular factors involved in the estab-
The specificity of five monoclonal antibodies, D2/8-1,
lishment and maintenance of JEV persistency will aid our
Na39-3.1, Na41-2, JE7/45-2, and Na81-2.1, against JEV
understanding of viral replication and chronic disease
NS1 used in this study was further confirmed by Western
state of JEV infection.
blotting and immunoprecipitation using antigen source
derived from the lysate of BHK-21 cells expressing NS1
MATERIALS AND METHODS by a recombinant plasmid, pJNS1/cDNA3, under CMV
promoter control (unpublished data). All five antibodiesCell lines and viruses
recognized native forms of NS1, but when the lysate was
The cell lines used to establish JEV persistency in this boiled in the presence of 2-mercaptoethanol prior to
study were as follows: N18, a mouse neuroblastoma cell SDS–PAGE, only antibody D2/8-1 detected denatured
line (Amano et al., 1972) (a kind gift from Dr. D. E. Griffin, forms of NS1 (data not shown). These data indicated that
Johns Hopkins University, Baltimore MD); Vero, a monkey D2/8-1 recognized a linear epitope of NS1, and that the
kidney cell line; and DBT, a mouse astrocytoma cell line remaining antibodies recognized conformational epi-
(Hirano et al., 1974). C2-2 was a clone selected by limiting topes on NS1. The epitope location recognized by D2/8-
dilution (see below) from the persistently JEV-infected 1 was characterized by several NS1 deletion mutants
N18 cells. All cells were grown in RPMI 1640 medium expressed in BHK-21 cells, and the result showed that
containing 10% fetal calf serum (FCS). A JEV strain RP9, the epitope was located in the N-terminal one-third of
a plaque-purified virus from a Taiwan local strain NT- NS1 (data not shown). Using synthetic peptides for fine
109 which was originally isolated from infected mosquito mapping, the epitope of D2/8-1 was mapped to a 16-mer
Cx. tritaeniorhynchus, was used throughout this study. peptide whose sequence was TELRYSWKTWGKAKM
The propagation of virus was carried out in BHK-21 cells (data not shown); this peptide contained a consensus
using RPMI 1640 medium containing 2% FCS. Virus titers linear sequence [WK(A/T)WGK] present in the NS1 of
were determined by plaque-forming assay on BHK-21 JEV, Kunjin virus, and dengue virus (Falconar and Young,
cells. 1991; Falconar et al., 1994).
Cloning of persistently infected cells Indirect immunofluorescence staining
Cells were fixed by acetone/methanol (1/1) solution forLimiting dilution was used to clone persistently in-
fected cells. Briefly, the bulk of persistently JEV-infected 5 min, stained with JEV-specific polyclonal or monoclonal
antibodies at room temperature for 1 hr. The dilutions ofN18 cells was trypsinized and washed once with com-
plete RPMI 1640 medium. Cell suspensions were antibodies used in this assay were 1:500 or 1:1000. After
AID VY 7755 / 6a11$$$362 02-01-96 19:58:52 vira AP: Virology
222 CHEN ET AL.
washing with phosphate-buffered saline (PBS), the cells leukemia viral reverse transcriptase (Bethesda Research
Laboratories), 50 mM Tris–HCl (pH 8.3), 75 mM KCl, 3were reacted with goat anti-mouse fluorescein-conju-
gated secondary antibody (Cappel) and examined under mM MgCl2 , 10 mM DTT, and 1 mM each dATP, dGTP,
dCTP, and dTTP. Using primer sets a and b or c and d,a Leitz fluorescent microscope.
2 ml of the resulting first-strand cDNA sample was PCR-
Cell labeling and immunoprecipitation amplified in 100 ml of reaction mixture containing 5 units
of Taq polymerase (Perkin–Elmer); 2 mM MgCl2 ; 1 mMCell monolayers were starved with methionine- and
each dATP, dGTP, dCTP, and dTTP; 20 mM Tris–HCl (pHcysteine-free RPMI 1640 for 1 hr and labeled with 50
8.4); 50 mM KCl. Thirty-five cycles of amplification weremCi of 35S Pro-Mix (Amersham) per 35-mm dish for 4
performed by using a PCR thermocycler (AG 9600 Ther-hr at 377. The cells were rinsed and lysed with lysis
mal Station; AcuGen System). Each cycle consisted of abuffer (1% NP-40, 150 mM NaCl, 50 mM Tris – HCl, pH
denaturation step at 947 for 30 sec followed by a primer-7.5, 1 mM EDTA) containing a cocktail of protease in-
annealing step at 557 for 30 sec and a primer extensionhibitors, 20 mg/ml phenylmethylsulfonyl fluoride, 2 mg/
step at 727 for 30 sec, except for a longer denaturationml leupeptin, and 2 mg/ml aprotinin. Aliquots of cell
step (5 min) and a longer primer extension step (10 min)lysates were mixed with polyclonal or monoclonal anti-
at the first and last cycle.bodies captured on Staphylococcal protein A-coated
Sepharose (Pharmacia) for 1 hr at room temperature.
DNA sequencingThe immune complexes were washed with RIPA buffer
(10 mM Tris – HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, PCR products were purified from agarose gel by Qia-
0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate), quick gel extraction kit (Qiagen) and sequenced with
analyzed by 10% SDS – polyacrylamide gel electropho- Sequenase PCR product sequencing kit (United States
resis, and fluorographed at 0707. Biochemical) following the manufacturer’s instructions
based on the Sanger dideoxynucleotide method (Sanger
Western immunoblot analysis et al., 1977).
Cell lysates were mixed with an equal volume of the
sample buffer (50 mM Tris–HCl, pH 6.8, 100 mM dithio- RESULTS
threitol (DTT), 2% SDS, 0.1% bromophenol blue, 10% glyc-
Establishment of persistent JEV infection in mouseerol) lacking 2-mercaptoethanol with or without boiling,
neuroblastoma N18 cellsseparated by SDS–PAGE, and transferred to nitrocellu-
lose membrane (Hybond-C Super; Amersham). The non- A mouse neuroblastoma cell line N18 was used to
specific antibody-binding sites were blocked with 5% establish a persistent JEV infection in cell culture. Like
skimmed milk in PBS, and the filters were incubated with primary infection of BHK-21 cells, JEV is cytolytic to most
monoclonal anti-JEV NS1 antibodies. The blot was then N18 cells and the virus yield obtained from this primary
treated with horseradish peroxidase-conjugated goat infection was approximately 1 1 107 PFU/ml. N18 cells
anti-mouse immunoglobulin (Cappel) and developed with were first infected with a plaque-purified JEV strain RP9
4-chloro-1-naphthol. at a multiplicity of infection (m.o.i.) of 10. At 30 hr postin-
fection (p.i.), severe cytopathic effects (CPE) in infected
RNA preparation and RT–PCR reaction
cells were observed, and more than 90% of the cells
were lysed by 40 hr p.i. The remaining cells from primaryViruses harvested from the media of the JEV-infected
cell cultures were incubated with lysis buffer (4 M guani- JEV infection were again infected with JEV at m.o.i. 10
for further selection of surviving cells. After three consec-dine thiocyanate, 50 mM Tris–HCl, pH 8.5, 10 mM EDTA,
0.5% sarcosyl) for 15 min at 47 and extracted twice with utive cycles of selection, surviving cells were maintained
and grown into a stable cell population without apparentan equal volume of acid phenol/chloroform (Chomczyn-
ski and Sacchi, 1987). RNA in the aqueous phase was CPE. The growth rate of this cell population was about
30% slower than the normal N18 cells. To determineprecipitated by isopropanol. Four different primers were
used in the amplification reaction. Primers a [5*-GCG- whether this was a persistent JEV infection in N18 cells,
indirect immunofluorescence assay (IFA) using virus-ATCCAGACACTGGATGTGCCA-3 *, (/) sense], b [5*-
GCGGATCCTAAGCATCAACCTGTGA-3 *, (0) sense], c specific antibodies was carried out to detect viral anti-
gens expressed in these cells; about 90% of the cells[5*-GCATTCTCTTTGCCCCGGAATTGGC-3 *, (/) sense],
and d [5*-GGAAGGGGAGACAAGCAGATCAACC-3 *, (0) showed microscopically strong positive staining in the
cytoplasm (data not shown). In addition, a virus titer ofsense] correspond to nucleotides 2478–2501, 3510 –
3534, 2133–2157, and 2839–2863 of the JEV cDNA, re- about 103 to 104 PFU/ml was continuously detected in
the culture media from bulk cells during the 6-monthspectively. Using primer b or d, 5 mg of purified RNA was
transcribed into first-strand cDNA at 427 for 1 hr in 20 ml period. These results indicated that these cells had been
persistently infected with JEV.of reaction buffer containing 200 units of Moloney murine
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TABLE 1
Properties of Cell Clones Isolated from JEV-Infected N18 Bulk Cells
Without SIa WIth SI
Expression of Expression of viral
viral proteins proteins
Virus titer Virus titer
Clone (PFU/ml) IFA RIP RT–PCR (PFU/ml) IFA RIP
C1-1 0 0 0 Nob 9.6 1 105 / /
C1-2 0 0 0 No 7.7 1 105 / /
C2-1 0 0 0 No 3.3 1 105 / /
C2-2 2.1 1 103 / / / 2.1 1 103 / /
C2-3 0 0 0 No 3.1 1 105 / /
a SI, superinfection with JEV.
b No, no PCR products detected.
In an attempt to obtain persistently JEV-infected cell the C2-2 clone. Therefore, the antigen-negative clones
were indeed cured of viral infection during passages.clones, the bulk cells were cloned by limiting dilution as
described under Materials and Methods. Among 31 cell The susceptibility of C2-2 cells to infection by a heterol-
ogous virus, Sindbis virus, which is a prototype alphavi-clones established by such a manner, 5 clones were
rus, was investigated. Severe CPE and cell death wererandomly chosen for further studies, and some of their
observed at 12 hr p.i. in C2-2 cells and at 24 hr p.i. incharacteristics are shown in Table 1. During 5-month
the parental N18 cells, indicating that C2-2 cells, similarpassages, only 1 clone, C2-2, continued to release a low
to N18 cells, were susceptible to heterologous viral infec-titer of virus into medium, and nearly 100% of cells in
tion. Together, these data, including the continuous re-this clone showed positive IFA staining with antibodies
lease of infectious virus, the presence of viral antigensagainst viral proteins (Table 1). However, as analyzed by
and RNA genomes in the cells, and the susceptibility toinfectious center assay, only 1% of C2-2 cells were capa-
heterologous but not homologous viral superinfection,ble of shedding infectious virus. The reason for the dis-
clearly indicate that C2-2 is a bona fide persistently JEV-crepancy between the results of IFA and infectious cen-
infected cell clone.ter assay for this clone was unclear (see below under
Discussion). The remaining clones had apparently been
Comparison of viral protein expression betweencured of viral infection during passages, as evidenced
primary and persistent infectionby negative IFA staining and lack of viable virus produc-
tion. The susceptibility of these cell clones to superinfec- To study the expression profiles of viral protein in per-
tion by homologous viruses was examined (Table 1). sistently infected cells, [35S]methionine-labeled cell ly-
After superinfection with JEV-RP9 at m.o.i. 50, all 5 clones sates from primary infection of N18 cells and from persis-
showed positive IFA staining; however, all but C2-2 tent infection of C2-2 were precipitated by JEV-specific
showed severe CPE at 30 hr p.i. and were lysed by 40 antibodies and separated by SDS–PAGE (Fig. 1). When
hr p.i.; in addition, all of the clones except C2-2 released using monoclonal antibodies specific for either E (Fig. 1,
infectious virus to a titer of about 105 PFU/ml into the lanes 3 and 4) or NS3 (Fig. 1, lanes 7 and 8), the patterns
medium (Table 1), indicating that they were susceptible of viral antigen expressions were similar between pri-
to homologous superinfection to almost the same extent mary and persistent infections, although the amounts of
as primary infection in N18 cells, although the virus yield proteins varied. It was not clear why there was slightly
was slightly lower than that from primary infection of N18 more NS3 precipitated in the C2-2 cells (Fig. 1, lane 8)
cells (about 5 1 107 PFU/ml). By contrast, the C2-2 clone than in the primarily infected N18 cells (lane 7). In con-
was resistant to homologous superinfection since no trast, when JEV-specific polyclonal antiserum (Fig. 1,
CPE and no changes in virus titers were observed after lanes 1 and 2) or monoclonal antibodies specific for NS1
superinfection (Table 1). (Fig. 1, lanes 5 and 6) were used, two additional proteins
To determine whether all the other clones were indeed with faster mobility, p45 and p39, were observed in per-
‘‘cured’’ of viral infection, RT–PCR was performed to de- sistently infected C2-2 cells (lanes 2 and 6), but not in
tect the possible existence of viral genome in four viral primarily infected N18 cells (lanes 1 and 5).
antigen-negative clones, C1-1, C1-2, C2-1, and C2-3 (Ta- To determine whether this difference in NS1 protein
ble 1). The result showed that none of these clones con- pattern could also be seen between the C2-2 and the
viral antigen-negative cell clones described in Table 1,tained JEV RNA; in contrast, JEV RNA was detected in
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FIG. 3. Immunoblot analysis of NS1 and its derivatives from JEV
primary and persistent infections. Cell lysates from mock infection of
N18 (lane 1), from primary infection of N18 (lanes 2 and 3), and from
persistent infection of C2-2 cells (lanes 4 and 5) were separated by
FIG. 1. Comparison of viral antigens expressed between the primarily 10% SDS–PAGE and immunoblotted with anti-NS1 monoclonal anti-
JEV-infected N18 cells and the persistently infected clone C2-2. [35S]- body JE7/45-2. Protein samples were treated either with boiling (D,
Methionine-labeled lysates from N18 and C2-2 cells were immunopre- lanes 2 and 4) or without boiling (0, lanes 3 and 5). Monomeric NS1,
cipitated either with polyclonal antiserum specific for JEV (antiserum, NS1*, p45, and p39 are marked by arrows. Molecular weight markers
lanes 1 and 2) or with monoclonal antibodies specific for E (aE, lanes in kDa are on the left.
3 and 4), NS1 (aNS1, lanes 5 and 6), or NS3 (aNS3, lanes 7 and 8).
The positions of each viral protein in 10% SDS–PAGE are indicated
p45 and p39. As expected, only C2-2 cells (Fig. 2, laneby arrows. Note that two additional proteins, p45 and p39, were found
9) and not the other clones (Fig. 2, lanes 6 to 8 and 10),in C2-2 cell lysates when precipitated by polyclonal antiserum (lane 2)
and by anti-NS1 monoclonal antibodies (lane 6). expressed NS1 protein in the absence of JEV superinfec-
tion, consistent with the result of immunofluorescence
described in Table 1. These results indicate that the ab-we carried out immunoprecipitation of NS1 in the six
normal NS1 expression in C2-2 cells is a property associ-clones after superinfection with JEV (Fig. 2). All four anti-
ated with persistently infected viral genome.gen-negative clones expressed normal NS1 and NS1*
To determine whether the truncation of the NS1 was(Fig. 2, lanes 1 to 3 and 5), whereas only C2-2 (Fig. 2,
an inherent property of the viruses released from thelane 4) produced the two additional abnormal proteins,
persistently infected C2-2 cells, fresh N18 cells were
infected with these viruses and the pattern of NS1 pro-
teins in the infected cells was analyzed. To eliminate the
possible influence from DI particles, the released viruses
from C2-2 were first amplified once in BHK-21 cells at
m.o.i. 0.01. Similar to the primary JEV infections, the pri-
mary infection of N18 cells with the viruses released from
C2-2 resulted in lytic infection after 30-hr incubation, and
no abnormal forms of NS1 proteins were detected in the
infected cells (data not shown). These results suggested
that the aberrant NS1 expression was not an inherent
property of the viruses released from C2-2 cells, but most
likely the result of virus–cell interaction associated with
persistent infection.
Characterization of the truncated NS1 proteins from
persistently infected C2-2 cells
FIG. 2. Expression patterns of NS1 with or without JEV superinfection To determine if the faster migrating proteins, p45 and
from five clones derived from the persistently infected N18 bulk cells. p39, detected in the persistently infected C2-2 cells are
Five clones, with (lanes 1 to 5) or without JEV superinfection (lanes 6 truncated forms of NS1 or cellular proteins associated
to 10), were radioisotope-labeled, and the cell lysates were immunopre-
with NS1, we carried out immunoblotting analysis usingcipitated by anti-NS1 monoclonal antibodies. The positions of p45 and
a monoclonal antibody, JE7/45-2, specific for NS1. Asp39 are marked by asterisks. Numbers are the molecular weights in
kDa indicated on the left. shown in Fig. 3, when protein samples were heat-dena-
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NS1s in C2-2 cells. Both NS1 and NS1* contain two pre-
dicted glycosylation sites at the amino acid positions 105
and 182 (Fig. 5A), and glycosylated moieties are about 6
kDa in mass. After complete digestion by endoglycosylase
F (Endo F), the sizes of NS1 and NS1* decreased from 48
to 42 kDa and from 55 to 49 kDa, respectively, as expected
(compare Fig. 5B, lane 1 with 4, and 2 with 5). Interestingly,
both p45 and p39 also were susceptible to Endo F diges-
tion: their sizes were reduced from 45 to 40 kDa and from
39 to 33 kDa, respectively, after Endo F digestion (Fig. 5B,
compare lane 3 with 6). These results suggest that, in C2-
2 cells, (i) the generation of the truncated NS1s did not
interfere with the normal glycosylation of wild-type NS1 and
NS1*; (ii) the truncated NS1s, like their wild-type counter-
parts, are translocated into ER and glycosylated; and (iii) the
FIG. 4. Localization of the truncation of NS1 and its derivatives to truncated proteins p45 and p39 retained both glycosylation
their N-termini in C2-2 cells by immunoprecipitation using anti-NS1 sites. These results, combined with the failure of antibody
monoclonal antibodies. (A) Schematic diagram of monoclonal antibody
D2/8-1 to recognize p45 and p39, suggest that these twoD2/8-1 which binds to the N-terminal one-third of NS1 and recognizes
proteins likely have truncations in their N-terminal 105tha common linear epitope (90WK(A/T)WGK95) (see Materials and Meth-
ods). (B) 35S-labeled lysates from C2-2 cells were precipitated by five amino acid. Their possible relationships are indicated in
anti-NS1 monoclonal antibodies, Na39-3.1, Na41-2, JE7/45-2, Na81-2.1, Fig 5A: p45 might be the truncated form of NS1*, whereas
and D2/8-1 (lanes 1 to 5), and then separated by 10% SDS–PAGE. The p39 might be the truncated form of NS1, both having an
wild-type NS1 and NS1* are marked with arrows, and the truncated
approximate 10-kDa deletion.proteins of p45 and p39 are positioned by asterisks.
Detection of truncated NS1 in other persistently JEV-
infected cellstured prior to electrophoresis, the monomeric forms of
To determine whether the truncation of NS1 and NS1*NS1 and NS1* of normal sizes were both detected in
is a general characteristic of JEV persistent infection,primary infection of N18 (lane 2). In C2-2 cells, both p45
and p39, in addition to the normal NS1 and NS1*, were
detected (lane 4). In the absence of heat denaturation,
all of the NS1 migrated as the homo- and heterodimeric
forms (Fig. 3, lanes 3 and 5) (Lee et al., 1991; Fan and
Mason, 1990; Flamand et al., 1992). These results clearly
indicate that both p45 and p39 are the truncated forms
of JEV NS1.
To further understand the structure of p45 and p39,
we performed immunoprecipitation using five different
anti-NS1 monoclonal antibodies (see Materials and
Methods). Among them, four monoclonal antibodies,
Na39-3.1, Na41-2, JE7/45-2, and Na81-2.1, have pre-
viously been shown to recognize conformational epi-
topes of NS1 although the precise epitopes have not
been mapped (see Materials and Methods). The results
FIG. 5. The analysis of glycosylated modifications of NS1, NS1*, and
showed that all four antibodies precipitated the wild-type their truncated derivatives by Endo F digestion. (A) Schematic diagram
NS1 and NS1* as well as p45 and p39 (Fig. 4B). It was of the NS1, NS1*, and their truncated products shown in rectangles.
The glycosylation sites are indicated by arrowheads on the top ofunclear why p45 and p39 were more efficiently precipi-
the rectangles. The dashed lines at the N-termini of rectangles aretated than NS1 and NS1* by these monoclonal antibodies
designated as the predicted truncation regions of NS1 in C2-2 cells.(Fig. 4B). In contrast, monoclonal antibody D2/8-1, which
The expected changes of molecular weights from precipitated NS1s
has been characterized to recognize a linear epitope treated either without (0) or with (/) Endo F digestion are numerically
located at the amino acid positions 90 to 95 in the N- depicted at the right of each rectangle. (B) Cell lysates from JEV primary
infection of BHK-21 (lanes 1 and 4) and N18 cells (lanes 2 and 5) andterminal one-third of JEV NS1 (Fig. 4A; see Materials and
from persistent infection of C2-2 cells (lanes 3 and 6) were immunopre-Methods), precipitated only the wild-type NS1 and NS1*
cipitated by anti-NS1 monoclonal antibodies and then were treatedand not the truncated NS1s (Fig. 4B, lane 5). This result
either without (lanes 1 to 3) or with (lanes 4 to 6) Endo F at 377 for 16
strongly suggests that both p45 and p39 observed in C2- hr. The deglycosylated NS1 and NS1* (lanes 4 to 6) are indicated by
2 cells are truncated at their N-termini. arrows, and the deglycosylated truncated p45 and p39 (lane 6) are
marked by asterisks.We next examined the glycosylation status of truncated
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cipitated by antiserum, extra protein bands migrating
faster than the normal NS1 were detected from all persis-
tent infections of C2-2 (Fig. 6, lane 2), Vero (lane 3), and
DBT cells (lane 8). These abnormal proteins were trun-
cated NS1 proteins, as demonstrated by immunoprecipi-
tation by monoclonal antibodies against NS1. In persis-
tently infected Vero cells, two faster migrating proteins
(Fig. 6, lane 6), which closely resembled the truncated
NS1s p45 and p39, seen in C2-2 cell lysate, were de-
tected (lane 5). As a control, primary infection of Vero
cells did not express these faster migrating proteins
(data not shown). In contrast, in persistently infected DBT
cells only one species of faster migrating protein was
detected (Fig. 6, lane 10). Again, this truncated NS1 pro-
tein was not detected in primary infection (Fig. 6, lane
9). Taken together, these results clearly indicate a strong
relationship between abnormal NS1 expression and JEV
persistency in cell cultures.
FIG. 6. Detection of truncated NS1 in several persistently infected cell
lines. [35S]Methionine-labeled lysates were immunoprecipitated with Analysis of the NS1-coding region on virus RNA
either polyclonal antiserum specific for JEV (antiserum, lanes 1 to 3 isolated from persistent infection of N18 cells
and 7 and 8) or with monoclonal antibodies specific for NS1 (aNS1,
lanes 4 to 6 and 9 and 10). Cell lysates isolated from primary JEV To establish the origin and nature of the NS1 trunca-
infections comprise N18 (lanes 1 and 4) and DBT (lanes 7 and 9); tions in C2-2 cells, we carried out RT–PCR and direct
lysates from persistent infections include C2-2 (lanes 2 and 5), Vero sequencing to study the possible deletions and/or muta-(lanes 3 and 6), and DBT (lanes 8 and 10). Immunoprecipitations were
tions in the viral genomic RNA in C2-2 cells. Total RNAanalyzed by SDS–10% PAGE. The truncated NS1s are indicated by
purified from C2-2 cells was amplified by RT–PCR usingasterisks.
primer pairs as described in Fig. 7A. The positions of
primers chosen were based on the assumption that the
truncated NS1s should still contain the signal peptideswe examined the NS1 protein in two other persistently
at their N-termini (Flamand et al., 1992) in order to beinfected cell lines established in Vero and DBT cells.
translocated into the ER for proper glycosylation. As dem-The establishment of JEV persistency in Vero cells was
onstrated in Fig. 7B, both C2-2 cells and primary infectionsimilar to that in N18 cells; primary infection of JEV
of N18 cells yielded PCR products of identical sizes; nocauses a severe CPE in Vero cells at 30 hr p.i., and90%
truncated PCR products were detected in C2-2 cells (Fig.of the infected cells were lysed at 40 hr p.i. Surviving
7B, lanes 2 to 5). To detect mutations, we directly se-cells were grown into a cell population and showed a
quenced the RT–PCR products purified from agarose gelslight morphological change. The growth rate of these
in Fig. 7B, lanes 4 and 5. Primer d (Fig. 7A) was usedcells was about 30% slower than that of the uninfected
here as a sequencing primer to analyze the sequencesVero cells. JEV persistency in these Vero cells was veri-
around the junction of the predicted truncation site onfied by positive IFA staining of viral protein and continu-
NS1. The results demonstrated that no mutation wasous release of infectious virus for more than 3 months
found in the PCR products from persistent infection of(data not shown). By contrast, the establishment of JEV
C2-2 cells, compared to that from primary infection of N18persistency in DBT cells was significantly different from
cells (data not shown). Moreover, the sequence result ofthat in N18 and Vero cells. After infection, no obvious
PCR products purified from Fig. 7B, lanes 2 and 3, whichCPE was seen in DBT cells, although the infected cells
cover the entire NS1-coding region, revealed that no mu-grew about 30% slower than did uninfected DBT cells.
tation was found in NS1 from C2-2 cells compared toDuring passages, such infected DBT cells were periodi-
that from primary infection of N18 cells (data not shown).cally checked for their viral antigen expression and virus
Thus, these results suggest that the truncations of NS1release; about 90% of the cells were shown to have posi-
and NS1* seen in persistent infection of C2-2 cells didtive IFA staining in the cytoplasm (data not shown), and
not result from the mutations of the NS1 gene in thevirus titers ranging from 104 to 105 were detected in cul-
viral RNA, but most likely resulted from posttranslationalture media for more than 3 months. These results indi-
cleavage caused by defects in other genes.cate that these cells were persistently infected with JEV.
NS1 expressed in persistently JEV-infected Vero and
DISCUSSIONDBT cells was investigated by immunoprecipitation using
virus-specific antiserum (see Materials and Methods) We have successfully established persistent JEV infec-
tion in murine neuroblastoma cells (N18), murine astrocy-and anti-NS1 monoclonal antibodies (Fig. 6). When pre-
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the failure of antibody D2/8-1 to recognize p45 and p39
(Fig. 4) and (ii) the possession of normal glycosylated
moieties of the truncated p45 and p39, similar to that of
their counterpart wild-type NS1s (Fig. 5). However, our
data indicated that no mutation was detected in the NS1
region of the viral genome in C2-2 cells, suggesting that
the truncations of NS1 and NS1* seen in C2-2 cells did
not result from the mutations in the NS1 gene, but most
likely resulted from posttranslational cleavage caused by
defects in other genes. It is necessary in the future to
examine whether there is mutation in other viral genes
leading to aberrant expression of NS1 in C2-2 cells.
The biosynthesis of flavivirus NS1 has been demon-
strated to utilize the cellular secretory pathway, i.e., ER
and Golgi complex (Mason, 1989; Fan and Mason, 1990;
Blitvich et al., 1995). Conceivably, the truncation of NS1
in C2-2 cells was a result of an aberrant proteolytic cleav-
age, which occurred within ER or Golgi apparatus after
the translocation of NS1. The protease responsible for
this cleavage is unlikely to be the known viral protease
FIG. 7. Analysis by RT–PCR and direct sequencing of the NS1 coding NS3, which is a trypsin-like serine protease responsible
regions on viral RNAs isolated from JEV primary infection of N18 cells for the cleavages of NS2A-2B, NS2B-3, NS3-4A, and
and from persistent infection of C2-2 cells. (A) Schematic diagram of
NS4B-5, since its cellular location is mainly in the cyto-the primers used in RT–PCR analysis. The locations and polarities of
plasm (reviewed in Chambers et al., 1990). A cellulareach primer are shown by numbers and arrows, respectively. The prim-
ers a and c are in the same polarity as virus genomic RNA, whereas protease or an unknown viral protease present in ER or
the primers b and d are complementary to the virus genomic RNA. The Golgi apparatus of C2-2 cells is likely involved in this
locations of primers a and c start from their 5*-end corresponding to the cleavage event. The coexistence of the wild-type and the
nucleotide positions 2478 and 2133 on the virus genome, respectively;
truncated NS1s in all JEV-persistent cells (Figs. 3 andprimers b and d start at 3534 and 2863, respectively. (B) RT–PCR
7) indicated that this aberrant proteolytic cleavage wasproducts analyzed by agarose gel electrophoresis. Total RNA, isolated
from primary infection of N18 cells and from persistent infection of C2- incomplete, suggesting that the activity of the putative
2 cells, was subjected to RT–PCR using primer pairs of a and b (lanes protease is tightly regulated. We have failed to identify
2 and 3) and of c and d (lanes 4 and 5) as shown in A. PCR products the cause of abnormal cleavage; nonetheless, we have
were assayed by gel electrophoresis and stained with ethidium bro-
established the association between NS1 truncation andmide. Markers in lane 1 are fX174-HaeIII fragments. The predicted
JEV persistency in various culture systems.lengths of RT–PCR products are indicated by arrowheads accompa-
nied by numbers in nucleotides. The resulting frame is shown in its Whether the generation of truncated NS1s is a cause
negative. or an effect of JEV persistency in cell cultures remains
unclear. Nonetheless, our data do indicate that the ex-
pression of truncated NS1s is a dominant phenotype (Fig.
toma cells (DBT), and Vero cells. In particular, the estab- 2) associated with the maintenance of JEV persistency
lishment of viral persistency in the C2-2 cell clone, de- in a variety of cell lines. The establishment of persistent
rived from the persistently infected N18 cells, provides infection is a dynamic process as a result of interaction
an important system for studying the persistent JEV infec- between virus and host. The NS1 truncation could be a
tion in neuronal cells. The main finding of this study result of change of host cells, altering the specificity of
is the detection of truncated NS1s which were tightly viral or cellular proteases. Conceivably, JEV persistency
associated with JEV persistency in various cell lines. We in C2-2 cell requires the relative ratio between the wild-
have recently also observed an aberrant NS1 expression type and the truncated NS1s to regulate the balance
in the persistent JEV infection of NT2 cells, a human between lytic infection and temperate persistency, pre-
neuronal progenitor cell line (unpublished observation). sumably through interfering with the process of viral as-
The generality of this abnormal NS1 expression pattern sembly when nucleocapsid buds into the lumen of the
associated with all of the persistently infected cells stud- ER (reviewed in Chambers et al., 1990). This hypothesis
ied so far strongly suggests that NS1 plays a crucial role is supported in part by our observation that both the wild-
in JEV persistency. Thus, the aberrant NS1 expression type and the truncated NS1s were detected in all of the
pattern may be used as a molecular marker for the identi- persistently infected cell lines (Fig. 6). In addition, flavi-
fication of JEV persistency. viral NS1 protein has been suggested to play a role in
The truncation of NS1s in C2-2 cells likely resides in the process of virion assembly or maturation within the
cellular secretory pathway (Mason, 1989; Fan and Ma-their N-terminal 105th amino acid, as evidenced by (i)
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son, 1990). This interpretation is also consistent with the between abnormal NS1 expression and JEV persistency;
(iv) the truncation of NS1 in C2-2 cells probably resultedfinding that all of the cells showed positive viral antigen
staining and yet only 1% of cells released viruses in the from an additional posttranslational proteolytic cleavage
occurring in the persistently infected cells; and (v) theseinfectious cell center, and the culture produced very low
virus titers (Table 1). results suggest a probable involvement of dysfunctional
NS1 in the establishment and/or maintenance of JEV per-The shift from cytolytic infection to persistent infection
in a susceptible cell must be occurring under strong sistency in culture systems.
selective pressures on both the virus and the host. As
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